Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    February 2017
  1. BLAJ C, Schmidt EM, Lamprecht S, Hermeking H, et al
    Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations.
    Cancer Res. 2017 Feb 15. pii: canres.2821.2016.
    PubMed     Text format     Abstract available


  2. TONG J, Wang P, Tan S, Chen D, et al
    Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells.
    Cancer Res. 2017 Feb 15. pii: canres.3242.2016.
    PubMed     Text format     Abstract available


    January 2017
  3. ROKAVEC M, Hermeking H
    Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis.
    Cancer Res. 2017 Jan 27. pii: canres.3236.2016.
    PubMed     Text format     Abstract available


  4. MATHOT L, Kundu S, Ljungstrom V, Svedlund J, et al
    Somatic ephrin receptor mutations are associated with metastasis in primary colorectal cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1921.2016.
    PubMed     Text format     Abstract available


    November 2016
  5. CEJAS P, Cavazza A, Yandava C, Moreno V, et al
    Transcriptional regulator CNOT3 defines an aggressive colorectal cancer subtype.
    Cancer Res. 2016 Nov 29. pii: canres.1346.2016.
    PubMed     Text format     Abstract available


  6. USHIJIMA T, Yoshino T
    The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer.
    Cancer Res. 2016;76:6443-6444.
    PubMed     Text format    


    October 2016
  7. ZHANG M, Xu C, Wen L, Han MK, et al
    A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.1681.2016.
    PubMed     Text format     Abstract available


  8. ESSIEN BE, Sundaresan S, Ocadiz-Ruiz R, Chavis A, et al
    Transcription factor ZBP-89 drives a feedforward loop of beta-catenin expression in colorectal cancer.
    Cancer Res. 2016 Oct 10. pii: canres.3150.2015.
    PubMed     Text format     Abstract available


    September 2016
  9. HORN T, Ferretti S, Ebel N, Tam A, et al
    High order drug combinations are required to effectively kill colorectal cancer cells.
    Cancer Res. 2016 Sep 22. pii: canres.3425.2015.
    PubMed     Text format     Abstract available


    August 2016
  10. DI CECILIA S, Zhang F, Sancho-Medina A, Li S, et al
    RBM-AS1 is critical for self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 Aug 12. pii: canres.1824.2015.
    PubMed     Text format     Abstract available


  11. LIMAGNE E, Euvrard R, Thibaudin M, Rebe C, et al
    Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predict the efficacy of a FOLFOX-bevacizumab drug treatment regimen.
    Cancer Res. 2016 Aug 5. pii: canres.3164.2015.
    PubMed     Text format     Abstract available


  12. BENJAMIN LE
    Commentary on "KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer".
    Cancer Res. 2016;76:4309-10.
    PubMed     Text format    


    July 2016
  13. DE LA CHAPELLE A
    Colon Cancer Germline Genetics: The Unbelievable Year 1993 and Thereafter.
    Cancer Res. 2016;76:4025-7.
    PubMed     Text format    


    June 2016
  14. SU L, Luo Y, Yang Z, Yang J, et al
    MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Cancer Res. 2016 Jun 30. pii: canres.0246.2016.
    PubMed     Text format     Abstract available


  15. KUO WT, Lee TC, Yu LC
    Eritoran suppresses colon cancer by altering a functional balance in Toll-like receptors that bind lipopolysaccharide.
    Cancer Res. 2016 Jun 21. pii: canres.0172.2016.
    PubMed     Text format     Abstract available


  16. ODDO D, Sennott EM, Barault L, Valtorta E, et al
    Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer.
    Cancer Res. 2016 Jun 16. pii: canres.0396.2016.
    PubMed     Text format     Abstract available


    May 2016
  17. ALEKSANDROVA K, Giuseppe RD, Isermann B, Biemann R, et al
    Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC - Potsdam Cohort Study.
    Cancer Res. 2016 May 23. pii: canres.3464.2015.
    PubMed     Text format     Abstract available


  18. ZHOU J, Wang H, Zhang H, Lutz AM, et al
    VEGFR2-targeted three-dimensional ultrasound imaging can predict responses to anti-angiogenic therapy in preclinical models of colon cancer.
    Cancer Res. 2016 May 20. pii: canres.3271.2015.
    PubMed     Text format     Abstract available


  19. GIRAUD J, Failla LM, Pascussi JM, Lagerqvist EL, et al
    Autocrine secretion of progastrin promotes the survival and self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 May 4. pii: canres.1497.2015.
    PubMed     Text format     Abstract available


    April 2016
  20. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    PubMed     Text format     Abstract available


  21. SRINIVASAN T, Walters J, Bu P, Than EB, et al
    NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer Initiating Cells.
    Cancer Res. 2016 Apr 11. pii: canres.3198.2015.
    PubMed     Text format     Abstract available


    March 2016
  22. BHATTACHARYA R, Ye XC, Wang R, Ling X, et al
    Intracrine VEGF Signaling Mediates the Activity of Pro-survival Pathways in Human Colorectal Cancer Cells.
    Cancer Res. 2016 Mar 17. pii: canres.1605.2015.
    PubMed     Text format     Abstract available


  23. RAYNAL NJ, Lee JT, Wang Y, Beaudry A, et al
    Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Cancer Res. 2016;76:1494-505.
    PubMed     Text format     Abstract available


    February 2016
  24. RADHAKRISHNAN P, Ruh N, Harnoss JM, Kiss J, et al
    Prolyl hydroxylase 3 attenuates MCL-1-mediated ATP production to suppress the metastatic potential of colorectal cancer cells.
    Cancer Res. 2016 Feb 26. pii: canres.1474.2015.
    PubMed     Text format     Abstract available


  25. IM HJ, Kim HG, Lee JS, Kim HS, et al
    A Preclinical Model of Chronic Alcohol Consumption Reveals Increased Metastatic Seeding of Colon Cancer Cells in the Liver.
    Cancer Res. 2016 Feb 8. pii: canres.2114.2015.
    PubMed     Text format     Abstract available


  26. RAO CV, Sanghera S, Zhang Y, Biddick L, et al
    Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
    Cancer Res. 2016;76:630-42.
    PubMed     Text format     Abstract available


  27. MARUSIAK AA, Stephenson NL, Baik H, Trotter EW, et al
    Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
    Cancer Res. 2016;76:724-35.
    PubMed     Text format     Abstract available


    January 2016
  28. JOO JH, Oh H, Kim M, An EJ, et al
    NADPH oxidase 1 activity and ROS generation are regulated by Grb2/Cbl-mediated proteasomal degradation of NoxO1 in colon cancer cells.
    Cancer Res. 2016 Jan 18. pii: canres.1512.2015.
    PubMed     Text format     Abstract available


  29. LIN JE, Colon-Gonzalez F, Blomain E, Kim GW, et al
    Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Cancer Res. 2016;76:339-46.
    PubMed     Text format     Abstract available


  30. PRABHU VV, Hong B, Allen JE, Zhang S, et al
    Small molecule prodigiosin restores p53 tumor suppressor activity in chemoresistant colorectal cancer stem cells via c-Jun-mediated DeltaNp73 inhibition and p73 activation.
    Cancer Res. 2016 Jan 12. pii: canres.2430.2014.
    PubMed     Text format     Abstract available


  31. XING C, Lu XX, Guo PD, Shen T, et al
    Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
    Cancer Res. 2016;76:83-95.
    PubMed     Text format     Abstract available


  32. TAVARE R, Escuin-Ordinas H, Mok S, McCracken MN, et al
    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Cancer Res. 2016;76:73-82.
    PubMed     Text format     Abstract available


    December 2015
  33. CHEN HN, Yuan K, Xie N, Wang K, et al
    PDLIM1 stabilizes the E-cadherin/beta-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells.
    Cancer Res. 2015 Dec 23. pii: canres.1962.2015.
    PubMed     Text format     Abstract available


  34. CATALANO V, Dentice M, Ambrosio R, Luongo C, et al
    Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling.
    Cancer Res. 2015 Dec 16. pii: canres.1542.2015.
    PubMed     Text format     Abstract available


  35. DAVIDSON LA, Callaway ES, Kim E, Weeks BR, et al
    Targeted Deletion of p53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  36. UTTAM S, Pham HV, LaFace J, Leibowitz B, et al
    Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens.
    Cancer Res. 2015;75:4718-27.
    PubMed     Text format     Abstract available


  37. NAGARSHETH N, Peng D, Kryczek I, Wu K, et al
    PRC2 epigenetically silences Th1-type chemokines to suppress effector T cell trafficking in colon cancer.
    Cancer Res. 2015 Nov 13. pii: canres.1938.2015.
    PubMed     Text format     Abstract available


    October 2015
  38. HAM B, Wang N, D'Costa Z, Fernandez MC, et al
    TNF receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases.
    Cancer Res. 2015 Oct 19. pii: canres.3173.2014.
    PubMed     Text format     Abstract available


  39. GALLAGHER FA, Sladen H, Kettunen MI, Serrao EM, et al
    Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors.
    Cancer Res. 2015;75:4109-18.
    PubMed     Text format     Abstract available


    September 2015
  40. YANG H, Yamazaki T, Pietrocola F, Zhou H, et al
    STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells.
    Cancer Res. 2015;75:3812-22.
    PubMed     Text format     Abstract available


  41. NGIOW SF, Young A, Jacquelot N, Yamazaki T, et al
    A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1.
    Cancer Res. 2015;75:3800-11.
    PubMed     Text format     Abstract available


  42. RIGONI A, Bongiovanni L, Burocchi A, Sangaletti S, et al
    Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
    Cancer Res. 2015;75:3760-70.
    PubMed     Text format     Abstract available


  43. ZHAN QM, Chen J, Lan T, Zhang W, et al
    Feed forward reciprocal activation of PAFR and STAT3 regulates epithelial-mesenchymal transition in non-small cell lung cancer.
    Cancer Res. 2015 Sep 10. pii: canres.1062.2015.
    PubMed     Text format     Abstract available


  44. SANMAMED MF, Rodriguez I, Schalper KA, Onate C, et al
    Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rgammanull Immunodeficient Mice.
    Cancer Res. 2015;75:3466-78.
    PubMed     Text format     Abstract available


  45. MABY P, Tougeron D, Hamieh M, Mlecnik B, et al
    Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.
    Cancer Res. 2015;75:3446-55.
    PubMed     Text format     Abstract available


    April 2015
  46. BUCKEL L, Savariar EN, Crisp JL, Jones KA, et al
    Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
    Cancer Res. 2015;75:1376-87.
    PubMed     Text format     Abstract available


  47. GAJADHAR AS, Johnson H, Slebos RJ, Shaddox K, et al
    Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity.
    Cancer Res. 2015;75:1495-503.
    PubMed     Text format     Abstract available


  48. FOX JL, Storey A
    BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs.
    Cancer Res. 2015;75:1345-55.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: